Literature DB >> 3874905

Bronchoalveolar cells from sarcoid patients demonstrate enhanced antigen presentation.

V M Lem, M F Lipscomb, J C Weissler, G Nunez, E J Ball, P Stastny, G B Toews.   

Abstract

The recognition of foreign antigens by T lymphocytes in association with lung antigen-presenting cells may be critical in the initiation of the mononuclear alveolitis and granuloma formation of pulmonary sarcoidosis. However, it has been shown that bronchoalveolar cells (BAC) from normal volunteers function poorly as antigen-presenting cells. Therefore, the ability of sarcoid BAC to serve as accessory cells for antigen-dependent autologous T cell proliferation, as measured by tritiated thymidine uptake, was compared with that of normal BAC. Although irradiated sarcoid BAC supported antigen-induced T cell proliferation, normal BAC did so poorly (p less than 0.005). Because it has been shown that sarcoid BAC produce more interleukin 1 (IL 1) than normal BAC, it was considered that the enhancement of antigen-induced proliferative responses could result from an increased amount of IL 1, and that contaminating monocytes in the peripheral blood T cell preparations displayed the antigen for T cell recognition. Therefore, it was necessary to establish that antigen-induced T cell responses required HLA-D region compatibility between the sarcoid BAC and T lymphocytes. BAC from sarcoid patients stimulated antigen-specific proliferation in T cells lines matched for at least one HLA-D-region antigen, but failed to stimulate T cell lines that were unmatched for both antigens. This finding indicates that cells in bronchoalveolar lavage fluids from sarcoid patients were fully capable of acting as antigen-presenting cells. The identification of antigen-presenting cells in the lungs of patients with sarcoidosis together with the previous findings of activated T cells, enhanced IL 1 production, and spontaneous interleukin 2 release in sarcoid patients is compatible with the hypothesis that local cell-mediated immunity is involved in the pathogenesis of pulmonary sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3874905

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.

Authors:  J Wahlström; M Berlin; C M Sköld; H Wigzell; A Eklund; J Grunewald
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

2.  Sarcoidosis and inflammatory eye disease.

Authors:  J V Forrester
Journal:  Br J Ophthalmol       Date:  1992-04       Impact factor: 4.638

3.  Phenotypic markers of alveolar macrophage maturation in pulmonary sarcoidosis.

Authors:  I Stríz; Y M Wang; H Teschler; C Sorg; U Costabel
Journal:  Lung       Date:  1993       Impact factor: 2.584

Review 4.  Pathogenesis of sarcoidosis.

Authors:  K Van Gundy; O P Sharma
Journal:  West J Med       Date:  1987-08

5.  Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers.

Authors:  J M Löfdahl; J Wahlström; C M Sköld
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

6.  Pulmonary alveolar macrophages in patients with sarcoidosis and hypersensitivity pneumonitis: characterization by monoclonal antibodies.

Authors:  C Agostini; L Trentin; R Zambello; M Luca; M Masciarelli; A Cipriani; G Marcer; G Semenzato
Journal:  J Clin Immunol       Date:  1987-01       Impact factor: 8.317

7.  Pulmonary alveolar macrophages from patients with active sarcoidosis express type IV collagenolytic proteinase. An enzymatic mechanism for influx of mononuclear phagocytes at sites of disease activity.

Authors:  C Agostini; S Garbisa; L Trentin; R Zambello; G Fastelli; M Onisto; A Cipriani; G Festi; D Casara; G Semenzato
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

Review 8.  Cells and molecules involved in the development of sarcoid granuloma.

Authors:  C Agostini; U Basso; G Semenzato
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

9.  Correlation of GM-CSF mRNA in bronchoalveolar fluid with indices of clinical activity in sarcoidosis.

Authors:  A Itoh; E Yamaguchi; K Furuya; N Hizawa; N Ohnuma; Y Kawakami; N Kuzumaki
Journal:  Thorax       Date:  1993-12       Impact factor: 9.139

10.  Effects of intratracheal administration of nuclear factor-kappaB decoy oligodeoxynucleotides on long-term cigarette smoke-induced lung inflammation and pathology in mice.

Authors:  Yu-Tao Li; Bei He; Yu-Zhu Wang; Jing Wang
Journal:  Respir Res       Date:  2009-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.